In a key development for Pakistan’s pharmaceutical sector, Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has successfully exported Centrum—a ...
Multivitamin and cocoa extract supplements do not protect against clinical fractures for older adults, according to data ...
Haleon Pakistan Limited has announced its first international shipment of locally manufactured Centrum multivitamins to Kenya ...
Sensodyne, a leading oral care brand from Haleon (formerly GlaxoSmithKline Consumer Healthcare), sets a GUINNESS WORLD RECORD™ for successfully attempting the ‘Most online dental screening tests ...
Haleon's dividend grew 10% and is well-covered by FCF, but the 1.6% yield is less attractive compared to peers. See why I ...
Learn more about whether Haleon plc or Intra-Cellular Therapies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
HL Building Blocks Build your own portfolio with HL's specially designed fund range Wealth Shortlist A selection of funds we've researched and chosen for their long-term potential ...
Haleon plc (NYSE: HLN) Q4 2024 Earnings Call Transcript February 27, 2025 Haleon plc misses on earnings expectations.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
We believe Haleon is in fine financial health. In preparation of separating from GSK, its former parent, Haleon took on roughly GBP 10 billion in debt and post spinning out the company in July 2022 it ...
Haleon projects a gradual revenue and profit growth towards the second half of 2025, despite strong end-year sales in 2024.
Haleon projects a gradual revenue and profit ... The company, which makes Sensodyne toothpaste, ENO antacids and Centrum multivitamins, projected organic revenue would grow between 4 per cent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results